Endothelial dysfunction in PCOS: role of obesity and adipose hormones
- PMID: 16564785
- DOI: 10.1016/j.amjmed.2005.10.059
Endothelial dysfunction in PCOS: role of obesity and adipose hormones
Abstract
Purpose: Polycystic ovary syndrome (PCOS) is an extremely prevalent disorder in which elevated blood markers of cardiovascular risk and altered endothelial function have been found. This study was designed to determine if abnormal carotid intima-media thickness (IMT) and brachial flow-mediated dilation (FMD) in young women with PCOS may be explained by insulin resistance and elevated adipocytokines.
Methods: A prospective study in 50 young women with PCOS (age: 25.2 +/- 1 years; body mass index [BMI]: 28.7 +/- 0.8) and 50 matched ovulatory controls (age: 25.1 +/- 0.7 years; BMI: 28.5 +/- 0.5) was performed. Carotid IMT, brachial FMD, and blood for fasting glucose, insulin, leptin, adiponectin and resistin were measured.
Results: PCOS, IMT was increased (P <.01), FMD was decreased (P <.01), fasting insulin was increased (P <.01), QUICKI (a marker of insulin resistance) was decreased (P <.01), and adiponectin was lower (P <.05), whereas leptin and resistin were not different compared with matched controls. Whereas BMI or waist/hip ratios did not correlate with IMT or FMD, insulin and QUICKI correlated positively and negatively with IMT (P <.01). There was a significant negative correlation between adiponectin and IMT (P <.05). These correlations were unchanged when adjusting for BMI and the correlation between IMT and adiponectin was unaffected by insulin resistance parameters.
Conclusions: These data suggest that young women with PCOS have evidence for altered endothelial function. Adverse endothelial parameters were correlated with insulin resistance and lower adiponectin. Both insulin resistance and adiponectin appear to be important parameters. It is hypothesized that the type of fat distribution may influence these factors.
Copyright 2006 Elsevier Inc. All rights reserved.
Similar articles
-
Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.J Soc Gynecol Investig. 2005 Feb;12(2):129-34. doi: 10.1016/j.jsgi.2004.09.003. J Soc Gynecol Investig. 2005. PMID: 15695109
-
Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.Mol Genet Metab. 2005 May;85(1):61-9. doi: 10.1016/j.ymgme.2004.12.014. Epub 2005 Feb 12. Mol Genet Metab. 2005. PMID: 15862282
-
Evidence for visfatin as an independent predictor of endothelial dysfunction in polycystic ovary syndrome.Clin Endocrinol (Oxf). 2012 Jan;76(1):119-25. doi: 10.1111/j.1365-2265.2011.04171.x. Clin Endocrinol (Oxf). 2012. PMID: 21740456
-
Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin.Obes Surg. 2005 May;15(5):692-9. doi: 10.1381/0960892053923789. Obes Surg. 2005. PMID: 15946462 Review.
-
Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence.Minerva Ginecol. 2004 Feb;56(1):27-39. Minerva Ginecol. 2004. PMID: 14973408 Review.
Cited by
-
Ovarian hypertension: polycystic ovary syndrome.Endocrinol Metab Clin North Am. 2011 Jun;40(2):433-49, ix-x. doi: 10.1016/j.ecl.2011.01.009. Endocrinol Metab Clin North Am. 2011. PMID: 21565677 Free PMC article.
-
The Impact of Diet-Induced Weight Loss on Inflammatory Status and Hyperandrogenism in Women with Polycystic Ovarian Syndrome (PCOS)-A Systematic Review and Meta-Analysis.J Clin Med. 2024 Aug 21;13(16):4934. doi: 10.3390/jcm13164934. J Clin Med. 2024. PMID: 39201076 Free PMC article. Review.
-
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome.touchREV Endocrinol. 2021 Apr;17(1):37-53. doi: 10.17925/EE.2021.17.1.37. Epub 2021 Apr 28. touchREV Endocrinol. 2021. PMID: 35118445 Free PMC article. Review.
-
[Polycystic ovary syndrome. Prototype of a cardio-metabolic syndrome].Internist (Berl). 2007 Feb;48(2):144-53. doi: 10.1007/s00108-006-1776-7. Internist (Berl). 2007. PMID: 17226011 Review. German.
-
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.Nat Rev Endocrinol. 2011 Apr;7(4):219-31. doi: 10.1038/nrendo.2010.217. Epub 2011 Jan 25. Nat Rev Endocrinol. 2011. PMID: 21263450 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical